During the past decade, Quantum Laboratories Memory Disorder Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Quantum Laboratories Memory Disorder Center" are "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Quantum Laboratories Memory Disorder Center" in a lesser frequency.

Most popular intervention types in "Quantum Laboratories Memory Disorder Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "GC021109" (1 trials), "Rivastigmine 13.3 mg/24 h (15 cm^2)" (1 trials), "Rivastigmine 4.6 mg/24 h (5 cm^2)" (1 trials) and "Rivastigmine 9.5 mg/24 h (10 cm^2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quantum Laboratories Memory Disorder Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Quantum Laboratories Memory Disorder Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Quantum Laboratories Memory Disorder Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quantum Laboratories Memory Disorder Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".